| Literature DB >> 35767530 |
Sameed Ahmed M Khatana1,2,3, Lin Yang2, Lauren A Eberly1,2,3,4, Howard M Julien1,2,4, Srinath Adusumalli1,2,3,4,5, Peter W Groeneveld2,3,6,7.
Abstract
Telemedicine utilization increased significantly in the United States during the COVID-19 pandemic. However, there is concern that disadvantaged groups face barriers to access based on single-center studies. Whether there has been equitable access to telemedicine services across the US and during later parts of the pandemic is unclear. This study retrospectively analyzes outpatient medical encounters for patients 18 years of age and older using Healthjump-a national electronic medical record database-from March 1 to December 31, 2020. A mixed effects multivariable logistic regression model was used to assess the association between telemedicine utilization and patient and area-level factors and the odds of having at least one telemedicine encounter during the study period. Among 1,999,534 unique patients 21.6% had a telemedicine encounter during the study period. In the multivariable model, age [OR = 0.995 (95% CI 0.993, 0.997); p<0.001], non-Hispanic Black race [OR = 0.88 (95% CI 0.84, 0.93); p<0.001], and English as primary language [OR = 0.78 (95% CI 0.74, 0.83); p<0.001] were associated with a lower odds of telemedicine utilization. Female gender [OR = 1.24 (95% CI 1.22, 1.27); p<0.001], Hispanic ethnicity or non-Hispanic other race [OR = 1.40 (95% CI 1.33, 1.46);p<0.001 and 1.29 (95% CI 1.20, 1.38); p<0.001, respectively] were associated with a higher odds of telemedicine utilization. During the COVID-19 pandemic, therefore, utilization of telemedicine differed significantly among patient groups, with older and non-Hispanic Black patients less likely to have telemedicine encounters. These findings are relevant for ongoing efforts regarding the nature of telemedicine as the COVID-19 pandemic ends.Entities:
Mesh:
Year: 2022 PMID: 35767530 PMCID: PMC9242497 DOI: 10.1371/journal.pone.0269535
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Patient characteristics by telemedicine utilization.
| Any telemedicine encounter | No telemedicine encounter | |
|---|---|---|
| Number of unique patients | 432,634 | 1,566,900 |
| Number of encounters (Mean, SD) | 4.1 (SD = 4.2) | 2.2 (SD = 2.2) |
| Age [years, Mean (SD)] | 53.0 (17.7) | 52.2 (18.3) |
| Female | 270,849 (62.6) | 893,166 (57.0) |
| Male | 161,785(37.4) | 673,734 (43.0) |
|
| ||
| Hispanic (any race) | 80,893 (29.1) | 182,548 (18.5) |
| Non-Hispanic Black | 38,618 (13.9) | 135,607 (13.7) |
| Non-Hispanic other race | 46,022 (16.6) | 141,504 (14.3) |
| Non-Hispanic White | 112,003 (40.4) | 528,787 (53.5) |
| Missing race/ethnicity data | 155,098 (35.8) | 578,454 (36.9) |
|
| ||
| Primarily English speaking | 218,766 (75.7) | 898,071 (84.4) |
| Primarily non-English speaking | 70,230 (24.3) | 166,548 (15.6) |
| Missing language data | 143,638 (33.2) | 502,281 (32.1) |
| Number of comorbidities (Mean, SD) | 1.5 (1.5) | 0.9 (1.2) |
|
| ||
| Northeast | 12,527 (2.9) | 143,491 (9.2) |
| Midwest | 68,254 (15.8) | 150,182 (9.6) |
| South | 207,829 (48.0) | 876,915 (56.0) |
| West | 144,024 (33.3) | 396,312 (25.3) |
Results are presented as number of patients and percentage of patients in group (telemedicine or non-telemedicine), unless otherwise indicated. All differences between the two groups are statistically significant at p<0.001.
a. Any telemedicine encounter includes patients with at least one telemedicine outpatient medical encounter from March 1, 2020 to December 31, 2021 and no telemedicine encounter indicates no telemedicine outpatient encounters during this period.
b. Proportion of patients with data available. Proportions of patients in each race/ethnicity and language sub-group after multiple imputation are listed in Table 3 in S1 Appendix.
c. Proportion of patients in each group with individual medical comorbidities listed in Table 4 in S1 Appendix.
Fig 1Proportion of patients with a telemedicine encounter (from March to December 2020) by 3-digit ZIP code.
Figure based on 2019 ZIP code tabulation area shapefile created by US Bureau and Helathjump data [20]. Map projection based on modification of the US National Atlas Equal Area coordinate reference system. Proportion of patients in the study population with at least one telemedicine encounter during the study period in each 3-digit ZIP code divided into quartiles. Areas with no ZIP code tabulation area code provided by the US Census Bureau include sparsely populated areas and areas such as military facilities.
Fig 2Monthly proportion of unique patients with outpatient telemedicine encounter from March to December 2020 by Social Vulnerability Index of 3-digit ZIP code of residence.
Social Vulnerability Index (SVI) based on Centers for Disease Control and Prevention methodology [9]. A higher value of SVI indicates greater degree of social vulnerability of an area to a health disaster. Patients with telemedicine encounters in one month, not included in calculation for subsequent months.
Multivariable mixed effects logistic regression model with any outpatient telemedicine encounter as outcome.
| Odds Ratio (95% CI) | p-value | |
|---|---|---|
| Age | 0.995 (0.993, 0.997) | <0.001 |
| Female | 1.24 (1.22, 1.27) | <0.001 |
| Non-Hispanic White |
| |
| Hispanic (Any race) | 1.40 (1.33, 1.46) | <0.001 |
| Non-Hispanic Black | 0.88 (0.84, 0.93) | <0.001 |
| Non-Hispanic other race | 1.29 (1.20, 1.38) | <0.001 |
| Primarily non-English speaking |
| |
| Primarily English speaking | 0.78 (0.74, 0.83) | <0.001 |
| Proportion of residents living in rural areas | 0.99 (0.98, 1.00) | 0.10 |
| Socioeconomic index | 1.01 (1.00, 1.02) | 0.02 |
| Household composition and disability index | 1.00 (0.99, 1.00) | 0.44 |
| Minority status and language index | 0.99 (0.98, 1.01) | 0.24 |
| Housing type and transportation index | 0.999 (0.997, 0.999) | 0.04 |
a. Sub-component of the CDC Social Vulnerability Index (SVI) based on Centers for Disease Control and Prevention methodology [9]. Higher value of SVI sub-component indicates greater degree of social vulnerability of an area to a health disaster.
Coefficients for indicator variables for medical comorbidities included in Table 5 in S1 Appendix.